CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 80 enrolled
Drug / intervention
Pharmacist Intervention in lipid therapyother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06647238
NCT06647238N/ACompleted
CompareCT.gov

Second Time's the Charm: Evaluation of Pharmacist Interventions in Lipid Management for Secondary Prevention

Wake Forest University Health Sciences·interventional·Posted Oct 17, 2024·Updated Jul 22, 2025

In Brief

A clinical study evaluating Pharmacist Intervention in lipid therapy for Hyperlipidemia and Coronary Artery Disease. Completed, enrolled 80 participants across 1 site.

Detailed Summary

The primary objective of this research project is to compare the effect of pharmacist interventions versus usual care in the implementation of guideline directed lipid lowering therapies for secondary prevention.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHyperlipidemia, Coronary Artery Disease
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20252026
First PostedOct 17, 2024
Enrollment StartNov 5, 2024
Primary CompletionMay 1, 2025
Study CompletionMay 27, 2025
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 1.7 years ago

Interventions

Pharmacist Intervention in lipid therapyother

Pharmacist intervention may include but is not limited to prescribing (statins, ezetimibe, bempedoic acid, PCSK9 inhibitors, etc.), patient education, and medication access.